January 22, 2018

Antidote for Eliquis Shows Positive Results

Here’s more good news about the upcoming antidote for Eliquis – see: Positive Results for Factor Xa Inhibitor Antidote: ANNEXA-A

Eliquis (apixaban) approved by US FDA for atrial fibrillation stroke prevention

Press Release: Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban) Friday, December 28, 2012 5:46 pm EST PRINCETON, N.J. & NEW YORK–Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved ELIQUIS® (apixaban). Please see full Prescribing Information including BOXED WARNING and Medication Guide […]

Atrial Fibrillation & Anticoagulants–StopAfib.org interviews Dr. Daniel Singer

StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: http://www.stopafib.org/newsitem.cfm/NEWSID/397 Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban […]

Apixaban (Eliquis) prevents more atrial fibrillation strokes than warfarin — March FDA approval expected

A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial […]